Literature DB >> 33194862

Erythromelalgia Caused by Polycythemia Vera Combined with Primary Aldosteronism.

Morika Suzuki1, Takashi Watari2.   

Abstract

A 61-year-old woman with a history of primary aldosteronism caused by unilateral hyperplasia of the adrenal gland presented with a 2-week history of redness and severe pain in the right thumb and thenar regions. She had initially visited a dermatologist and was diagnosed with cellulitis and treated with cefditoren pivoxil for 5 days, but there was no improvement. The pain worsened and was accompanied by a burning sensation. The dermatologist prescribed famciclovir for 5 days owing to suspicion of herpes zoster. The patient was then referred to our department because her symptoms persisted. Physical examination showed no abnormalities other than the redness in the right thumb and thenar regions and spontaneous moderate pain present throughout the right thumb. Investigations revealed normal blood chemistry and coagulation factor levels, except for elevated haemoglobin (18.2 g/dl). Further investigations revealed an erythropoietin level of 2.3 IU/ml and Janus kinase 2 mutation. Hence, we diagnosed the patient with erythromelalgia caused by polycythemia vera. In this report, we discuss the treatment of polycythemia causing erythromelalgia, and the aetiology of primary aldosteronism and polycythemia vera. LEARNING POINTS: Polycythemia can cause erythromelalgia, which should be treated with aspirin.Primary aldosteronism causes secondary erythropoiesis through activation of the renin-aldosterone system, but the mechanism is not clear.Erythropoiesis may be promoted by concurrent primary aldosteronism and polycythemia vera, resulting in secondary erythromelalgia. © EFIM 2020.

Entities:  

Keywords:  Erythromelalgia; polycythemia vera; primary aldosteronism

Year:  2020        PMID: 33194862      PMCID: PMC7654995          DOI: 10.12890/2020_001852

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  5 in total

1.  Bone marrow renin-angiotensin system expression in polycythemia vera and essential thrombocythemia depends on JAK2 mutational status.

Authors:  Maruska Marusic Vrsalovic; Vlatko Pejsa; Tajana Stoos Veic; Slobodanka Ostojic Kolonic; Radmila Ajdukovic; Visnja Haris; Ozren Jaksic; Rajko Kusec
Journal:  Cancer Biol Ther       Date:  2007-06-13       Impact factor: 4.742

2.  Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor.

Authors:  M B Marrero; B Schieffer; W G Paxton; L Heerdt; B C Berk; P Delafontaine; K E Bernstein
Journal:  Nature       Date:  1995-05-18       Impact factor: 49.962

Review 3.  Erythromelalgia: new theories and new therapies.

Authors:  J S Cohen
Journal:  J Am Acad Dermatol       Date:  2000-11       Impact factor: 11.527

Review 4.  Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management.

Authors:  Ayalew Tefferi
Journal:  Am J Hematol       Date:  2012-03       Impact factor: 10.047

5.  Enhanced erythropoiesis mediated by activation of the renin-angiotensin system via angiotensin II type 1a receptor.

Authors:  Hideki Kato; Junji Ishida; Shigehiko Imagawa; Tomoko Saito; Norio Suzuki; Toshiki Matsuoka; Takeshi Sugaya; Keiji Tanimoto; Takashi Yokoo; Osamu Ohneda; Fumihiro Sugiyama; Ken-ichi Yagami; Toshiro Fujita; Masayuki Yamamoto; Masaomi Nangaku; Akiyoshi Fukamizu
Journal:  FASEB J       Date:  2005-10-13       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.